Ohcanbohtosat - Brooke Beckett
- Čájehuvvo 1 - 2 / 2
-
1
Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates Dahkki Janelle Marie Meyer, Kelly S. Perlewitz, James B. Hayden, Yee-Cheen Doung, Arthur Hung, John T. Vetto, Rodney F. Pommier, Atiya Mansoor, Brooke Beckett, Alina Tudorica, Motomi Mori, Megan Holtorf, Aneela Afzal, William Woodward, Eve T. Rodler, Robin L. Jones, Wei Huang, Christopher W. Ryan
Almmustuhtton 2013Artigo -
2
Implementing a comprehensive translational oncology platform: from molecular testing to actionability Dahkki Zahi Mitri, Swapnil Parmar, Brett Johnson, Annette Kolodzie, Jamie M. Keck, Max Morris, Alexander R. Guimarães, Brooke Beckett, Uma Borate, Charles D. Lopez, Kathleen Kemmer, Joshi J. Alumkal, Tomasz M. Beer, Christopher L. Corless, Gordon B. Mills, Joe W. Gray, Raymond C. Bergan
Almmustuhtton 2018Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Bioinformatics
Biology
Breast cancer
Cancer
Chemoradiotherapy
Chemotherapy
Computational biology
Computer science
Epirubicin
Hepatocellular carcinoma
Internal medicine
Neutropenia
Oncology
Pathology
Radiation therapy
Radiology
Regimen
Sarcoma
Soft tissue
Soft tissue sarcoma
Sorafenib
Surgery